Le Lézard
Classified in: Health
Subject: LAW/LEGAL ISSUES

Don't Drive Hi campaign is buzzing -- Got a bad case of the munchies? Stay off the roads


TORONTO, ON--(Marketwired - July 14, 2017) - R.I.D.E CHECKS -- Don't add driving to your summer high! The warm weather often brings lots of cottage trips, festivals and concerts -- and sometimes the munchies too! Well, munch away but just don't get behind the wheel.

That's the message from a new awareness campaign, Don't Drive Hi, which is helping to help spread awareness that buzzed driving is just like drunk driving so stay off the roads. Despite weed becoming legally available across Canada by mid 2018, driving high is illegal -- and it will remain illegal.

"People don't necessarily associate being high with two things -- that they're impaired and they can lose their licence. We need to get the message out there," said Lorne Simon, founder of R.I.D.E. CHECKS and the lead on this ongoing important campaign to keep roads safe.

"We're not here to tell anyone not to smoke pot. We don't care if you're in the mood to finish off your third bag of cheese puffs, dig in but just don't drive!" said Simon.

That's the tone of the new Don't Drive Hi campaign -- cheeky and non-preachy -- featuring fictitious weed-friendly snacks in radio ads and on colourful diner menus to be handed out at large music events across the city. If a fish taco ice-cream Sunday ketchup bowl sounds appetizing then you're probably driving high and need to pull over!

The year-long Don't Drive Hi campaign is backed by forward-thinking sponsors and supporters including radio stations Z103.5 and Energy 108, licensed producer Beleave Inc., advertising agency BBDO, and safe driving advocates R.I.D.E. CHECKS and Arrive Alive DRIVE SOBER.

"There are extremely high social costs and harms attributed to cannabis-related motor vehicle collisions in Canada, including potential injury or loss of life," said Roger Ferreira, a neuroscientist at Beleave, a medical cannabis company. "As a company that cares about community and the people in it, Beleave is proud to support the Don't Drive Hi campaign."

"Beleave's support is paramount to the success of the Don't Drive Hi campaign", added Simon, "and in creating a culture where driving after consuming cannabis is never okay."

Legislation is still hazy but the impact and consequences of driving impaired are clearly devastating. A troubling new study from B.C. revealed that a high proportion of young adults who consume pot are driving. Study co-author Dr. Jeff Brubacher predicted that when marijuana is legalized, there will be an increase in crashes, injuries and fatalities.

Drugs and driving don't mix but the sobering truth is that people still do it. "Driving high is illegal and we don't discriminate between alcohol and drugs," said OPP Sgt. Kerry Schmidt. "We'll continue to patrol the roads and crack down on impairment."


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: